Mazin Sabra - 12 Mar 2026 Form 4 Insider Report for ClearPoint Neuro, Inc. (CLPT)

Reporting relationship: Chief Operating Officer
Issuer ticker: CLPT
Reported as of: 12 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 Mar 2026, 14:46:52 UTC
Prior SEC filing: 10 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Danilo D'Alessandro, by Power of Attorney for Mazin Sabra

Key filing fact

Mazin Sabra filed Form 4 for ClearPoint Neuro, Inc. (CLPT) on 16 Mar 2026.

Key facts

This page summarizes Mazin Sabra's Form 4 filing for ClearPoint Neuro, Inc. (CLPT).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 16 Mar 2026, 14:46.

Change

Previous filing in this sequence was filed on 10 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001947604 Primary reporting owner

SABRA MAZIN

Relationship: Chief Operating Officer
Address: C/O CLEARPOINT NEURO, INC., 120 S. SIERRA AVE., SUITE 100, SOLANA BEACH
Signature: /s/ Danilo D'Alessandro, by Power of Attorney for Mazin Sabra
Signature date: 16 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLPT transaction

Common Stock

Options Exercise

Transaction value
Shares: +26,101
Change %: +48%
Price
Shares after: 80,624
Date: 12 Mar 2026
Ownership: Direct
Footnotes: F1

CLPT transaction

Common Stock

Tax liability

Transaction value
Shares: -13,281
Change %: -16%
Price: $11.53^*
Shares after: 67,343
Date: 12 Mar 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CLPT transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -26,101
Change %: -50%
Price
Shares after: 26,101
Date: 12 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 26,101
Exercise price
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.

Footnote F2

Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock.